Parotid Neoplasms clinical trials

The registry lists 27 studies for Parotid Neoplasms across more than 10 countries. 7 are recruiting or about to start. 24 of them are mainly about Parotid Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Parotid Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 12
Recruiting: 6
Status unknown: 5
Active, not recruiting: 2
Not yet recruiting: 1
Withdrawn: 1

Phase

Phase 2: 3
Phase 1: 2
Early Phase 1: 2
Phase 3: 1

Where

United States: 6
France: 5
Egypt: 4
Italy: 2
Korea, Republic of: 1
Hong Kong: 1

Who runs them

Fondation Ophtalmologique Adolphe de Rothschild (2) · Mayo Clinic (1) · Chinese University of Hong Kong (1) · Alume Biosciences, Inc. (1) · Sohag University (1) · National Taiwan University Hospital (1) · Centre Hospitalier Universitaire de Nīmes (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

What is being tested here

Drugs under test in Parotid Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Pembrolizumab	0	0	1
Bevonescein	0	0	1
Cisplatin	0	0	1
Docetaxel	0	0	1
Bevacizumab	0	0	1
Erlotinib	0	0	1
Limonene	0	0	1

Coming up

0phase 3 studies under way

6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Dec 2026Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · M.D. Anderson Cancer Center
Jan 2027FArial NErf MRI in the Preoperative Assessment of PArotide Tumors · Fondation Ophtalmologique Adolphe de Rothschild
Feb 2027Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch · Sheba Medical Center
May 2027Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) · Merck Sharp & Dohme LLC
Jun 2027Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor · Centre Hospitalier Universitaire de Nīmes
Jun 2027Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation · Chinese University of Hong Kong

Who these studies take

Of the 6 Parotid Neoplasms studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	0 (0%)	0 (0%)
18	6 (100%)	6 (100%)
30	6 (100%)	6 (100%)
40	6 (100%)	6 (100%)
50	6 (100%)	6 (100%)
65	6 (100%)	6 (100%)
75	5 (83%)	5 (83%)
85	5 (83%)	5 (83%)

Across all 27 studies, recruiting or not: 15% stop at 75 or younger and 11% at 65; 11% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaNov 10, 2026NCT06421649

Studies

Recruiting first, then most recently updated. Showing 27 of 27. search them.